| Tag | Content |
|---|
EnhancerAtlas ID | HS176-17685 |
Organism | Homo sapiens |
Tissue/cell | SK-N-SH |
Coordinate | chr18:21108350-21109140 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxo1 | MA0480.1 | chr18:21109081-21109092 | TGTAAACAGCA | - | 6.14 | | NFE2L1 | MA0089.2 | chr18:21108727-21108742 | TCATGACTCAGCAGT | + | 7.08 | | Nfe2l2 | MA0150.2 | chr18:21108725-21108740 | CGTCATGACTCAGCA | + | 7.05 | | RUNX1 | MA0002.2 | chr18:21109120-21109131 | GTTTGTGGTTT | + | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_09888 | chr18:21108085-21111264 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH18I023528 | chr18 | 21107997 | 21110690 |
|
Enhancer Sequence | TTATCGCCAC CAATTCCCGC TGTATTACTT GTACATCATA TCTTCTGAAG CCAGAAGAAA 60
AGTTTAGGAC AAGGAGAATG AATTATTTCA ATTCCAGGAT CTGATTAGTC CTAGGCTGAA 120
AATGGTTTTA AACCAACAAA AGCCCCAGAA CTCCACTCCC CTTTAGCTGT TCATGGAAGG 180
GTAAGAGGTC TGAGACAGGC ACTGAAGAGG GCCAGTTGCT GGGACAGTGT CCATTCCTAC 240
GCTGCCAGAC GTGAGGGATG GCTGAGTCCT TTTGGACTCT ATTGCTGTGG GTGTTCTGGG 300
CTGTGGGAAT CAGTAGGTCT GATCCCAAAT GGCAGTTTCT GTGCCGTCCC ACACGGTCTG 360
CTGGGCTCCA TAAACCGTCA TGACTCAGCA GTGTGGGCCA CTGACCAGCC ACATGAGCAG 420
CATCTGGAGT TTCTTGGAAA TGCAAGTTCT CAGGCTACAC CCCACAGCTA TTGCATAATC 480
TGCACGGATC TGAACTGCTT TTTTTTTTTT GAGACGGAGT TTTGTTCTTA TTGCCCAGGC 540
TGGAGTGCAA TGGTGAGATC TTGGCTCACC GCAACCTCTG CCTCCTGGGT TCAAGGGATT 600
CTCCTGCCTC AGCCTCCTGA GTAGCTGGGA TTACAGGCAT GCGCACAGGA AAAAGTTGTA 660
TCTAAGTAGA GAAAGTGTTT TCCGCTCATA TCCTGGGTCC ACATCGAAGA ATTCAGTCCT 720
TGTGGATGAA CTGTAAACAG CACCCTTCCT CTAAGATGCC GAAGATCATA GTTTGTGGTT 780
TTTTTCTTTC 790
|
